Halothane hepatitis in a renal transplant patient previously exposed to isoflurane

Acute cholestatic hepatitis after exposure to isoflurane

OBJECTIVE

To report a case of acute cholestatic hepatitis following exposure to the inhalational anesthetic isoflurane.

CASE SUMMARY

A 70-year-old healthy woman from Iraq developed acute cholestatic hepatitis 3 weeks following repair of the right rotator cuff under general anesthesia. There was no evidence for viral, autoimmune, or metabolic causes of hepatitis. No other medications were involved except for dipyrone for analgesia. The alanine aminotransferase was elevated to a peak concentration of 1533 U/L and the serum bilirubin reached a peak of 17.0 mg/dL. There was slow improvement over 4 months. Accidental reexposure by the patient to dipyrone was uneventful.

DISCUSSION

The clinical and histologic picture of this case resembles halothane hepatitis, which has a significant mortality rate.

CONCLUSIONS

Isoflurane, a common anesthetic agent, can cause severe cholestatic hepatitis.

Gallstones and isoflurane hepatitis

This report is of a case of a previously fit 65-year-old woman who developed postoperative liver dysfunction following an anaesthetic involving isoflurane. Biliary ultrasound demonstrated gallstones. However, serum antibodies to trifluoroacetylated proteins were detected, suggesting that immune sensitisation to the anaesthetic could have contributed to the impaired liver function.